ABSI
Price
$2.62
Change
-$0.09 (-3.32%)
Updated
Jun 27 closing price
Capitalization
333.57M
51 days until earnings call
LTRN
Price
$3.18
Change
+$0.04 (+1.27%)
Updated
Jun 27 closing price
Capitalization
34.4M
37 days until earnings call
Interact to see
Advertisement

ABSI vs LTRN

Header iconABSI vs LTRN Comparison
Open Charts ABSI vs LTRNBanner chart's image
Absci
Price$2.62
Change-$0.09 (-3.32%)
Volume$7.4M
Capitalization333.57M
Lantern Pharma
Price$3.18
Change+$0.04 (+1.27%)
Volume$40.34K
Capitalization34.4M
ABSI vs LTRN Comparison Chart in %
Loading...
ABSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LTRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABSI vs. LTRN commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABSI is a Buy and LTRN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (ABSI: $2.62 vs. LTRN: $3.18)
Brand notoriety: ABSI and LTRN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABSI: 244% vs. LTRN: 71%
Market capitalization -- ABSI: $334.21M vs. LTRN: $34.4M
ABSI [@Biotechnology] is valued at $334.21M. LTRN’s [@Biotechnology] market capitalization is $34.4M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABSI’s FA Score shows that 0 FA rating(s) are green whileLTRN’s FA Score has 1 green FA rating(s).

  • ABSI’s FA Score: 0 green, 5 red.
  • LTRN’s FA Score: 1 green, 4 red.
According to our system of comparison, LTRN is a better buy in the long-term than ABSI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABSI’s TA Score shows that 2 TA indicator(s) are bullish while LTRN’s TA Score has 3 bullish TA indicator(s).

  • ABSI’s TA Score: 2 bullish, 6 bearish.
  • LTRN’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, LTRN is a better buy in the short-term than ABSI.

Price Growth

ABSI (@Biotechnology) experienced а -6.09% price change this week, while LTRN (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

ABSI is expected to report earnings on Aug 19, 2025.

LTRN is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABSI($334M) has a higher market cap than LTRN($34.4M). ABSI YTD gains are higher at: 0.000 vs. LTRN (-0.313). LTRN has higher annual earnings (EBITDA): -21.24M vs. ABSI (-93.91M). ABSI has more cash in the bank: 134M vs. LTRN (19.7M). LTRN has less debt than ABSI: LTRN (195K) vs ABSI (8.92M). ABSI has higher revenues than LTRN: ABSI (4.82M) vs LTRN (0).
ABSILTRNABSI / LTRN
Capitalization334M34.4M971%
EBITDA-93.91M-21.24M442%
Gain YTD0.000-0.313-
P/E RatioN/AN/A-
Revenue4.82M0-
Total Cash134M19.7M680%
Total Debt8.92M195K4,573%
TECHNICAL ANALYSIS
Technical Analysis
ABSILTRN
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
80%
Momentum
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
85%
MACD
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
82%
Advances
ODDS (%)
Bullish Trend 10 days ago
89%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 17 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ABSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LTRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ISSC13.950.73
+5.52%
Innovative Solutions and Support
TDG1499.1727.31
+1.86%
TransDigm Group
CPRI17.580.05
+0.29%
Capri Holdings Limited
DEA22.25-0.09
-0.40%
Easterly Government Properties
TPCS3.39-0.17
-4.78%
TechPrecision Corp

ABSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABSI has been loosely correlated with RXRX. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if ABSI jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABSI
1D Price
Change %
ABSI100%
-3.32%
RXRX - ABSI
61%
Loosely correlated
-6.85%
CRSP - ABSI
60%
Loosely correlated
N/A
BEAM - ABSI
58%
Loosely correlated
-1.98%
ABCL - ABSI
57%
Loosely correlated
-3.48%
NTLA - ABSI
48%
Loosely correlated
-0.52%
More

LTRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LTRN has been loosely correlated with MNMD. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if LTRN jumps, then MNMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LTRN
1D Price
Change %
LTRN100%
+1.27%
MNMD - LTRN
35%
Loosely correlated
-2.82%
IMNM - LTRN
35%
Loosely correlated
-0.23%
ATAI - LTRN
34%
Loosely correlated
-2.22%
DNA - LTRN
33%
Loosely correlated
-1.77%
ABSI - LTRN
33%
Loosely correlated
-3.32%
More